NFKB1 and Alzheimer disease: Moreover, omics sciences have partially revealed the potential interactome of the hAPPSw isoform at the olfactory level as well as the disruption of the IκBα-NFκB p65 complex during the neurodegenerative process, providing molecular features that may be used as novel olfactory drug target candidates to treat AD.